Bora Pharmaceutical makes strategic appointment to strengthen global manufacturing capabilities.

MISSISSAUGA (October 17, 2022) Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO), has appointed Don Liscombe as their Vice President and General Manager to lead its flagship manufacturing facility in North America, located in Mississauga,  Ontario, Canada. 

Don will be responsible for leading the ambitious growth plans for the Mississauga facility and its  current 400 strong workforce. Bringing a wealth of experience in pharmaceutical operations and the  contract manufacturing industry, Don is recognized for driving profitable growth through customer  service, employee engagement and a commitment to operational excellence. He has held  progressively senior roles in the industry, including General Manager and most recently as leader of  Regional Operational excellence at a global CDMO. 

Commenting on his appointment, Don Liscombe said “I am privileged to serve in an industry that  has a profound impact on people’s lives, and I am honoured to join the Bora team whose mission is  “Contributing to Better Health All Over the World”. 

“I am impressed by the company’s track record of delivering top-tier services to their customers and  I am truly excited to be joining them at a time of significant growth to reach more patient around the  world”. 

Bobby Sheng, CEO of Bora Pharmaceuticals commented; “we are delighted to be in a position to  attract a leader like Don into the organization, he brings invaluable CDMO knowledge and  experience to the team, and will help drive us towards our impressive growth strategy. 

ENDS 

Media contact 

Senior PR Executive, ramarketing  

Danny McIver, daniel.mciver@ramarketingpr.com 

 About Bora Pharmaceuticals: 

Bora Pharmaceuticals is a premier international CGMP CDMO specializing in complex oral solid  dosage, liquids, nasal sprays, ophthalmic, and semi-solids pharmaceutical Rx and OTC products for  Clinical through Commercial manufacturing and packaging. Bora owns and operates six state-of the-art CGMP manufacturing facilities (Taiwan and Canada) built to the highest international  standards for manufacturing, packaging, R&D, and analytical testing. Our TAA-compliant sites  deliver to more than 100 markets around the world including the USA, Canada, EU, Southeast Asia,  Middle East, and South and Central Americas.. For more information visit: www.boracorpcdmo.com